Pila Pharma (PILA.ST) Stock Price
Pila Pharma Price
Revenue has compounded at 21.7% per year over the past 6 years to 1.13 M SEK. Pila Pharma's net margin stands at -1,496.3%, up from -2,392.5% several years earlier.
Pila Pharma stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Pila Pharma business model & stock analysis
Frequently asked questions about Pila Pharma
Converted at the current exchange rate, the Pila Pharma share trades at 0.14 EUR (1.53 SEK).
The revenue cannot currently be calculated for Pila Pharma.
The expected profit of Pila Pharma is -5.47 M SEK. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Pila Pharma is currently -11.81. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Pila Pharma stock.
The P/S cannot be calculated for Pila Pharma currently.
The Eulerpool Quality Score for Pila Pharma is 4/10.
The ISIN of Pila Pharma is SE0015988274. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Pila Pharma is A3CT5N. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Pila Pharma is PILA.ST. The ticker symbol is used to trade Pila Pharma shares on the stock exchange.
Pila Pharma stock
Pila Pharma Peer Group
Pila Pharma FIGI
All fundamentals and in-depth analysis of Pila Pharma
Our stock analysis for Pila Pharma stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Pila Pharma. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.